MedTrace Logo

A Trial of Dexmedetomidine Hydrochloride Nasal Spray in Preoperative Sedation of Adults

NCT04383418 · Status: UNKNOWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 201

Last updated 2021-07-15

No results posted yet for this study

Summary

The study is being conducted to evaluate the efficacy, and safety of dexmedetomidine hydrochloride nasal spray for preoperative sedation in adults. To explore the reasonable dosage of dexmedetomidine hydrochloride nasal spray for preoperative sedation.

Conditions

  • Preoperative Sedation

Interventions

DRUG

dexmedetomidine nasal spray

dexmedetomidine nasal spray

DRUG

dexmedetomidine hydrochloride nasal spray blank preparation

dexmedetomidine hydrochloride nasal spray blank preparation

Sponsors & Collaborators

  • Jiangsu HengRui Medicine Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Changhong Miao, PhD · Zhongshan Hospital, Fudan University, Shanghai

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-31
Primary Completion
2021-06-02
Completion
2021-09-10

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04383418 on ClinicalTrials.gov